These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24798303)

  • 1. Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.
    Parpart S; Roessler S; Dong F; Rao V; Takai A; Ji J; Qin LX; Ye QH; Jia HL; Tang ZY; Wang XW
    Hepatology; 2014 Sep; 60(3):872-83. PubMed ID: 24798303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
    Li D; Liu X; Lin L; Hou J; Li N; Wang C; Wang P; Zhang Q; Zhang P; Zhou W; Wang Z; Ding G; Zhuang SM; Zheng L; Tao W; Cao X
    J Biol Chem; 2011 Oct; 286(42):36677-85. PubMed ID: 21878637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.
    Gao R; Cai C; Gan J; Yang X; Shuang Z; Liu M; Li S; Tang H
    Oncotarget; 2015 Mar; 6(8):6014-28. PubMed ID: 25714026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
    Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
    Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
    Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein.
    Zhang JW; Li Y; Zeng XC; Zhang T; Fu BS; Yi HM; Zhang Q; Jiang N
    Med Sci Monit; 2015 Mar; 21():667-73. PubMed ID: 25731670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
    Xiao F; Zhang W; Chen L; Chen F; Xie H; Xing C; Yu X; Ding S; Chen K; Guo H; Cheng J; Zheng S; Zhou L
    J Transl Med; 2013 Aug; 11():195. PubMed ID: 23967867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
    Tian Z; Yu T; Wei H; Ning N
    J Clin Lab Anal; 2020 Feb; 34(2):e23071. PubMed ID: 31693242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.